Clinical Characteristics and Outcomes in Patients With KRAS G12C Mutated Non-Small Cell Lung Cancer

被引：0
|
作者：
Pellini, B. [1 ]
Ganesan, V. [2 ]
Wan, F. [3 ]
Sankararaman, S. [4 ]
Manyanont, S. [4 ]
Akhave, N. [5 ]
Baggstrom, M. [4 ]
Ward, J. [4 ]
Waqar, S. [4 ]
Morgensztern, D. [4 ]
Govindan, R. [6 ]
Devarakonda, S. [4 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL USA
[2] Univ Missouri, Sch Med, Kansas City, MO 64108 USA
[3] Washington Univ, Sch Med, Div Publ Hlth Sci, St Louis, MO 14263 USA
[4] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] Siteman Canc Ctr, St Louis, MO USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Non-small cell lung cancer; KRAS G12C mutation; KRAS-mutant NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP07.13
引用
收藏
页码：S209 / S210
页数：2
相关论文
共 50 条
  • [1] KRAS G12C mutations in non-small cell lung cancer
    Li, J. J.
    Wu, X. J.
    Farzin, M.
    Bray, V.
    Williamson, J.
    Pal, A.
    Yip, P. Y.
    Hagelamin, A.
    Ding, P.
    Nindra, U.
    Vinod, S.
    French, B.
    Chua, W.
    Gupta, R.
    Cooper, W. A.
    Wang, B.
    Lee, C. S.
    HISTOPATHOLOGY, 2024, 85 : 25 - 25
  • [2] Characteristics and treatment outcomes in advanced stage non-small cell lung cancer patients with KRAS G12C mutation
    Illini, Oliver
    Fabikan, Hannah
    Hochmair, Maximilian J.
    Weinlinger, Christoph
    Krenbek, Dagmar
    Brcic, Luka
    Setinek, Ulrike
    Terbuch, Angelika
    Absenger, Gudrun
    Konji, Selma
    Valipour, Arschang
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (19-20) : 727 - 728
  • [3] Differences on immune biomarkers between KRAS G12C and KRAS non-G12C mutated non-small cell lung cancer
    Pinto, L. Masfarre
    Parreira, A. S. D. F. M.
    Unanua, N. Castro
    Rocha, P.
    Ruiz, I. Morilla
    Sanchez, L. Teijeira
    Clave, S.
    Gorro, N. Navarro
    Mora, R. Bach
    Sanchez, I.
    Campos, M. A. Galindo
    Garcia, A. Taus
    Martinez, A. Azkarate
    Fabregat, R. Marse
    Paricio, B. Bellosillo
    Arasanz, H.
    Aguillo, M. Martinez
    Arriola, E.
    ANNALS OF ONCOLOGY, 2023, 34
  • [4] Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients
    Si-Yang Liu
    Hao Sun
    Jia-Ying Zhou
    Guang-Ling Jie
    Zhi Xie
    Yang Shao
    Xian Zhang
    Jun-Yi Ye
    Chun-Xiang Chen
    Xu-Chao Zhang
    Qing Zhou
    Jin-Ji Yang
    Yi-Long Wu
    Biomarker Research, 8
  • [5] A retrospective study of the prevalence and clinical outcomes of KRAS G12C mutated advanced non-small cell lung cancer (NSCLC) in Australian patients (pts)
    Markman, B.
    Solomon, B.
    Nott, L. M.
    Roberts-Thomson, R.
    Hughes, B.
    Pavlakis, N.
    Davis, A.
    Brown, L. J.
    Parakh, S.
    Brungs, D.
    Bowyer, S. E.
    Nordman, I.
    Jennens, R.
    Warburton, L.
    Harris, S. J.
    Samuel, E.
    Ramanujam, S.
    Wang, A.
    Dumas, M.
    Gard, G.
    ANNALS OF ONCOLOGY, 2023, 34 : S1700 - S1700
  • [6] Dissecting the Clinical Characteristics and Treatment Outcomes Correlates of KRAS G12C-Mutated Non-Small Cell Lung Cancer
    Jing, Yawan
    Cheng, Ruixin
    Zeng, Hao
    Huang, Qin
    He, Dongyu
    Sun, Jiayi
    Tian, Panwen
    Li, Yalun
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 : 4507 - 4517
  • [7] Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer
    Alessandro Di Federico
    Ilaria Ricciotti
    Valentina Favorito
    Sandra Vietti Michelina
    Pietro Scaparone
    Giulio Metro
    Andrea De Giglio
    Federica Pecci
    Giuseppe Lamberti
    Chiara Ambrogio
    Biagio Ricciuti
    Current Oncology Reports, 2023, 25 : 1017 - 1029
  • [8] Clinical and Imaging Features of Non-Small Cell Lung Cancer with G12C KRAS Mutation
    Wu, Markus Y.
    Zhang, Eric W.
    Strickland, Matthew R.
    Mendoza, Dexter P.
    Lipkin, Lev
    Lennerz, Jochen K.
    Gainor, Justin F.
    Heist, Rebecca S.
    Digumarthy, Subba R.
    CANCERS, 2021, 13 (14)
  • [9] Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer
    Di Federico, Alessandro
    Ricciotti, Ilaria
    Favorito, Valentina
    Michelina, Sandra Vietti
    Scaparone, Pietro
    Metro, Giulio
    De Giglio, Andrea
    Pecci, Federica
    Lamberti, Giuseppe
    Ambrogio, Chiara
    Ricciuti, Biagio
    CURRENT ONCOLOGY REPORTS, 2023, 25 (09) : 1017 - 1029
  • [10] The immunotherapy role in patients (pt) with KRAS mutated metastatic non-small cell lung cancer (NSCLC): Differences between KRAS G12C and non-G12C
    Notario Rincon, L.
    Pous, A.
    Lopez-Paradis, A.
    Cerda, G.
    Cucurull, M.
    Hernandez, A.
    Domenech, M.
    Carcereny, E.
    Moran Bueno, M. T.
    Munoz, A.
    Mate, J. L.
    Sanz, C.
    Saigi, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S50 - S50
12345